BRAND NAME / COMPANY / REIMBURSEMENT AND LOGISTICS PROGRAM (APPROVED BY HEALTH CANADA FOR IBD INDICATIONS)

Humira®/AbbVie/AbbVie Care (2004)

Abrilada®/Pfizer/Pfizer Flex (2022)

Amgevita®/Amgen/Enliven (2021)

Hadlima®/Organon/Harmony by Organon™ (2021)

Hulio®/Biocon/My Biocon Biologics (2022)

Hyrimoz®/Sandoz/Xpose® (2021)

Idacio®/Fresenius Kabi/KabiCare® (2021)

Simlandi™/JAMP Pharma/JAMP Care (2022)

Yuflyma®/Celltrion/Celltrion Connect™ (2022)

CLASS

Monoclonal antibody
Tumour necrosis factor (TNF) blocking agent

ACTION

IBD causes the immune system to produce an excess amount of TNFα, which causes inflammation. Anti-TNFα is a protein that works to bind TNFα and block inflammation.